Home › Funds › Nexus Investment Management ULC › GILD

Nexus Investment Management ULC position in GILD

GILEAD SCIENCES INC · Health Care

Nexus Investment Management ULC reported holding 250,681 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$37.4M, representing 4.62% of its reported portfolio and ranking #9 among its reported holdings. Nexus Investment Management ULC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)250.68K sh
Reported value held$37.36M
Portfolio Weight4.62%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Nexus Investment Management ULC's GILD position evolved

Nexus Investment Management ULC first disclosed a stake in GILD in Q3 2023 at 291,968 shares (US$21.9M). The position peaked in Q1 2025 at 241,709 shares, worth US$39.0M. Across 13 filings, Nexus Investment Management ULC increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 250,681 shares valued at US$37.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 291.97K $21.88M New
Q4 2023 289.98K $23.49M Reduce
Q1 2024 289.48K $21.20M Hold
Q2 2024 288.42K $19.79M Hold
Q3 2024 283.06K $23.73M Reduce
Q4 2024 239.81K $22.15M Reduce
Q1 2025 241.71K $38.96M Add
Q2 2025 237.80K $26.37M Reduce
Q3 2025 259.02K $28.75M Add
Q4 2025 257.82K $31.65M Hold
Q1 2026 254.72K $35.50M Reduce
Q2 2026 251.02K $31.71M Reduce
Q3 2026 250.68K $37.36M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Nexus Investment Management ULC held GILD?

Nexus Investment Management ULC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Nexus Investment Management ULC's current position in GILD?

As of Q3 2026, Nexus Investment Management ULC holds 250.68K shares of GILD (GILEAD SCIENCES INC), valued at $37.36M, representing 4.62% of its reported portfolio and ranking #9.

Has Nexus Investment Management ULC been buying or selling GILD?

In the latest 13F filing (Q3 2026), Nexus Investment Management ULC held unchanged its position in GILD. The position peaked in Q1 2025 at 241.71K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.